Company intelligence / Profile preview

Bionov

Avignon, PACA, Francebionov.fr ↗

Ownership: Private
Development stage: Commercial

Overview

Bionov is the world’s largest industrial producer of 100% natural and bioactive SuperOxide Dismutase (SOD) from a proprietary variety of melon. Its flagship product, SOD B®, is a dried melon juice concentrate rich in SOD. The company has developed patented extraction and coating processes to ensure high bioactivity for both nutrition and cosmetic applications. Efficacy has been confirmed in several published clinical studies.

Therapeutic areas: OtherDermatology
Modalities: Natural bioactive enzymes (SuperOxide Dismutase/SOD)Plant-derived active ingredients
Industry: Non-Drug Biotech

Drug pipeline

3 assets

SOD B Dimpless

Commercial

Indications: Skin aging

2 more assets in the full pipeline.

Request access →

Partnerships

Robertet Group (global sales/distribution partnership)

Beyond the preview

Go deeper on Bionov.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bionov.

Explore the full profile